HOME >> BIOLOGY >> NEWS
Support for chromosomal theory of cancer found in cancers' development of drug resistance

Berkeley Thirty-six years into the war on cancer, scientists have not only failed to come up with a cure, but most of the newer drugs suffer from the same problems as those available in the pre-war days: serious toxicity, limited effectiveness and eventual resistance.

This is no surprise to University of California, Berkeley, genetics researcher Peter Duesberg, professor of molecular and cell biology. According to his novel yet controversial "chromosomal" theory of cancer, which is receiving increased attention among cancer researchers, each cancer is unique, and there is no magic bullet.

"The mutation theory of cancer says that a limited number of genes causes cancer, so cancers should all be more or less the same," Duesberg said. The chromosomal theory, which he laid out in an article in the May 2007 issue of Scientific American, implies instead that, "even if cancers are from the same tissue, and are generated with the same carcinogen, they are never the same. There is always a cytogenetic and a biochemical individuality in every cancer."

The most that can be expected from a drug, he said, is that it is less toxic to normal cells than cancer cells, and that as a result a cancer detected early can be knocked back by chemotherapy. His chromosomal theory offers hope of early detection, however, since it ascribes cancer to chromosomal disruption, called aneuploidy, that can be seen easily through a microscope.

"By screening for aneuploidy, you could detect the cancer early and also see what possible drugs to use and whether drugs would even help," Duesberg noted. "Then, you wouldn't have to give a cocktail of drugs that includes all the best poisons, but you could leave out those you could tell wouldn't work. If you could cut chemotherapy drug toxicity in half or two-thirds, and direct it better at cancer, that is some progress. But it is not a cure."

Duesberg and colleagues discuss the major problem of drug resis
'"/>

Contact: Robert Sanders
rsanders@berkeley.edu
510-643-6998
University of California - Berkeley
27-Jun-2007


Page: 1 2 3 4

Related biology news :

1. Support for fragile X syndrome needed
2. Support groups aid women with breast cancer gene mutations
3. Changes in chromosomal constitution of preimplantation embryos suggest caution in genetic screening
4. Speeding the search for elusive chromosomal errors
5. What controls stickiness of smart chromosomal glue
6. New gene associated with Fanconi anemia explains hallmark chromosomal instability
7. Agilent Technologies announces breakthrough for cancer researchers studying chromosomal changes
8. Autism theory put to the test with new technology
9. New genetic data overturn long-held theory of limb development
10. Oregon researchers involved in new Clovis-age impact theory
11. Water theory is watertight, researchers say

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/11/2019)... (PRWEB) , ... July 11, ... ... the world’s first on-site Legionella DNA test, today announced a partnership with ... hospitality industries. , Through this strategic partnership, LiquiTech will integrate Spartan’s innovative ...
(Date:7/9/2019)... ... July 08, 2019 , ... KMK Consulting, Inc. ... Cambridge, MA. This expansion strengthens KMK’s presence for the sales, support, and delivery ... force effectiveness consulting for the biotechnology corridor. With this expansion, KMK can ...
(Date:6/27/2019)... ... ... Lighting designers from integrated design firm LPA recently earned two ... both engaging and energy efficient lighting systems. , The lighting for the repositioning of ... California earned an IES Illumination Award of Merit in the Energy and Environment category. ...
Breaking Biology News(10 mins):
(Date:7/9/2019)... ... July 08, 2019 , ... Today, at the ... National Corn Growers Association (NCGA) announced the winners of the Consider Corn ... product or process using field corn to produce biobased materials. , “Corn is a ...
(Date:6/26/2019)... ... 26, 2019 , ... Alice Branton today released research results from preclinical trials ... Gluconate, which can prove to be beneficial for treating Hypomagnesemia. , The preclinical trial ... in crystallite size , Over 142% increase in particle size , ...
(Date:6/12/2019)... EGG HARBOR TOWNSHIP, N.J. (PRWEB) , ... June ... ... premier manufacturer of custom built, helium-based leak testing instruments for the Pharmaceutical, Biotechnology, ... partnership agreement with Shanghai Zillion has been signed. The agreement will grant exclusive ...
(Date:6/11/2019)... REDWOOD CITY, Calif. (PRWEB) , ... June 10, ... ... (IOPP) today announced IOPP will add 80 of its scientific journals to ... addition of physics-related content to DeepDyve’s continually expanding library of more than 20 ...
Breaking Biology Technology:
Cached News: